(Q59312604)
English
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements afte
scientific article published on 01 January 1999
Statements
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy (English)
C. Solá
P. Maroto
R. Salazar
R. Mesía
L. Mendoza
A. López-Pousa
J. M. Tabernero
J. Montesinos
C. Pericay
C. Martínez
J. A. Cancelas
J. J. López-López